Cargando…

Jie-Yu Pill, A Proprietary Herbal Medicine, Ameliorates Mood Disorder-Like Behavior and Cognitive Impairment in Estrogen-Deprived Mice Exposed to Chronic Unpredictable Mild Stress: Implication for a Potential Therapy of Menopause Syndrome

Jie-Yu Pill (JYP) is a proprietary herbal medicine initially developed to treat menstrual mood disorders. This study sought to determine whether JYP could alleviate menopausal psychiatric symptoms in ovariectomized (OVX) mice, an animal model of estrogen deprivation, exposed to chronic unpredictable...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Xi-Dan, Yang, Xin-Jing, Zheng, Yu, Qin, Zong-Shi, Sha, Wei, Chen, Gang, Zhang, Zhang-Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673394/
https://www.ncbi.nlm.nih.gov/pubmed/33329121
http://dx.doi.org/10.3389/fpsyt.2020.579995
_version_ 1783611310506770432
author Zhou, Xi-Dan
Yang, Xin-Jing
Zheng, Yu
Qin, Zong-Shi
Sha, Wei
Chen, Gang
Zhang, Zhang-Jin
author_facet Zhou, Xi-Dan
Yang, Xin-Jing
Zheng, Yu
Qin, Zong-Shi
Sha, Wei
Chen, Gang
Zhang, Zhang-Jin
author_sort Zhou, Xi-Dan
collection PubMed
description Jie-Yu Pill (JYP) is a proprietary herbal medicine initially developed to treat menstrual mood disorders. This study sought to determine whether JYP could alleviate menopausal psychiatric symptoms in ovariectomized (OVX) mice, an animal model of estrogen deprivation, exposed to chronic unpredictable mild stress (CUMS) and the underlying mechanisms in comparison with estrogen therapy. The OVX+CUMS mice were treated with 0.3 mg/kg estradiol (E(2)), 2.5 g/kg or 5 g/kg JYP for 36 days, and tested in multiple behavioral paradigms. Serum, uterus, and brain tissues were collected for the measurement of hypothalamus-pituitary-ovarian axis (HPO) and hypothalamus-pituitary-adrenal (HPA) axis hormones, γ-aminobutyric acid (GABA), glutamate, neurotrophins, and estrogen receptors. JYP and E(2) had comparable efficacy in reducing anxiety- and depression-like behavior and cognitive impairment of the OVX+CUMS mice. E(2) strikingly increased ratio of uterus to body weight of the OVX+CUMS mice, but JYP did not. Both agents suppressed HPO-axis upstream hormones, inhibited HPA-axis hyperactivity by reinstating hypothalamic GABA, restored hippocampal and prefrontal glutamate contents and its receptor expression in the OVX+CUMS mice. While JYP and E(2) protected against decreases in hippocampal and prefrontal neurotrophins and estrogen receptors of the OVX+CUMS mice, unlike E(2), JYP had no significant effects on these biomarkers in the uterus. These results suggest that JYP has comparable efficacy in ameliorating mood disorder-like behavior and cognitive impairment induced by a combination of estrogen deprivation and chronic stress in association with certain differential uterus-brain mechanisms compared to estrogen therapy. JYP may be a potential therapy for menopause-associated psychiatric disorders.
format Online
Article
Text
id pubmed-7673394
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-76733942020-12-15 Jie-Yu Pill, A Proprietary Herbal Medicine, Ameliorates Mood Disorder-Like Behavior and Cognitive Impairment in Estrogen-Deprived Mice Exposed to Chronic Unpredictable Mild Stress: Implication for a Potential Therapy of Menopause Syndrome Zhou, Xi-Dan Yang, Xin-Jing Zheng, Yu Qin, Zong-Shi Sha, Wei Chen, Gang Zhang, Zhang-Jin Front Psychiatry Psychiatry Jie-Yu Pill (JYP) is a proprietary herbal medicine initially developed to treat menstrual mood disorders. This study sought to determine whether JYP could alleviate menopausal psychiatric symptoms in ovariectomized (OVX) mice, an animal model of estrogen deprivation, exposed to chronic unpredictable mild stress (CUMS) and the underlying mechanisms in comparison with estrogen therapy. The OVX+CUMS mice were treated with 0.3 mg/kg estradiol (E(2)), 2.5 g/kg or 5 g/kg JYP for 36 days, and tested in multiple behavioral paradigms. Serum, uterus, and brain tissues were collected for the measurement of hypothalamus-pituitary-ovarian axis (HPO) and hypothalamus-pituitary-adrenal (HPA) axis hormones, γ-aminobutyric acid (GABA), glutamate, neurotrophins, and estrogen receptors. JYP and E(2) had comparable efficacy in reducing anxiety- and depression-like behavior and cognitive impairment of the OVX+CUMS mice. E(2) strikingly increased ratio of uterus to body weight of the OVX+CUMS mice, but JYP did not. Both agents suppressed HPO-axis upstream hormones, inhibited HPA-axis hyperactivity by reinstating hypothalamic GABA, restored hippocampal and prefrontal glutamate contents and its receptor expression in the OVX+CUMS mice. While JYP and E(2) protected against decreases in hippocampal and prefrontal neurotrophins and estrogen receptors of the OVX+CUMS mice, unlike E(2), JYP had no significant effects on these biomarkers in the uterus. These results suggest that JYP has comparable efficacy in ameliorating mood disorder-like behavior and cognitive impairment induced by a combination of estrogen deprivation and chronic stress in association with certain differential uterus-brain mechanisms compared to estrogen therapy. JYP may be a potential therapy for menopause-associated psychiatric disorders. Frontiers Media S.A. 2020-10-29 /pmc/articles/PMC7673394/ /pubmed/33329121 http://dx.doi.org/10.3389/fpsyt.2020.579995 Text en Copyright © 2020 Zhou, Yang, Zheng, Qin, Sha, Chen and Zhang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Zhou, Xi-Dan
Yang, Xin-Jing
Zheng, Yu
Qin, Zong-Shi
Sha, Wei
Chen, Gang
Zhang, Zhang-Jin
Jie-Yu Pill, A Proprietary Herbal Medicine, Ameliorates Mood Disorder-Like Behavior and Cognitive Impairment in Estrogen-Deprived Mice Exposed to Chronic Unpredictable Mild Stress: Implication for a Potential Therapy of Menopause Syndrome
title Jie-Yu Pill, A Proprietary Herbal Medicine, Ameliorates Mood Disorder-Like Behavior and Cognitive Impairment in Estrogen-Deprived Mice Exposed to Chronic Unpredictable Mild Stress: Implication for a Potential Therapy of Menopause Syndrome
title_full Jie-Yu Pill, A Proprietary Herbal Medicine, Ameliorates Mood Disorder-Like Behavior and Cognitive Impairment in Estrogen-Deprived Mice Exposed to Chronic Unpredictable Mild Stress: Implication for a Potential Therapy of Menopause Syndrome
title_fullStr Jie-Yu Pill, A Proprietary Herbal Medicine, Ameliorates Mood Disorder-Like Behavior and Cognitive Impairment in Estrogen-Deprived Mice Exposed to Chronic Unpredictable Mild Stress: Implication for a Potential Therapy of Menopause Syndrome
title_full_unstemmed Jie-Yu Pill, A Proprietary Herbal Medicine, Ameliorates Mood Disorder-Like Behavior and Cognitive Impairment in Estrogen-Deprived Mice Exposed to Chronic Unpredictable Mild Stress: Implication for a Potential Therapy of Menopause Syndrome
title_short Jie-Yu Pill, A Proprietary Herbal Medicine, Ameliorates Mood Disorder-Like Behavior and Cognitive Impairment in Estrogen-Deprived Mice Exposed to Chronic Unpredictable Mild Stress: Implication for a Potential Therapy of Menopause Syndrome
title_sort jie-yu pill, a proprietary herbal medicine, ameliorates mood disorder-like behavior and cognitive impairment in estrogen-deprived mice exposed to chronic unpredictable mild stress: implication for a potential therapy of menopause syndrome
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673394/
https://www.ncbi.nlm.nih.gov/pubmed/33329121
http://dx.doi.org/10.3389/fpsyt.2020.579995
work_keys_str_mv AT zhouxidan jieyupillaproprietaryherbalmedicineamelioratesmooddisorderlikebehaviorandcognitiveimpairmentinestrogendeprivedmiceexposedtochronicunpredictablemildstressimplicationforapotentialtherapyofmenopausesyndrome
AT yangxinjing jieyupillaproprietaryherbalmedicineamelioratesmooddisorderlikebehaviorandcognitiveimpairmentinestrogendeprivedmiceexposedtochronicunpredictablemildstressimplicationforapotentialtherapyofmenopausesyndrome
AT zhengyu jieyupillaproprietaryherbalmedicineamelioratesmooddisorderlikebehaviorandcognitiveimpairmentinestrogendeprivedmiceexposedtochronicunpredictablemildstressimplicationforapotentialtherapyofmenopausesyndrome
AT qinzongshi jieyupillaproprietaryherbalmedicineamelioratesmooddisorderlikebehaviorandcognitiveimpairmentinestrogendeprivedmiceexposedtochronicunpredictablemildstressimplicationforapotentialtherapyofmenopausesyndrome
AT shawei jieyupillaproprietaryherbalmedicineamelioratesmooddisorderlikebehaviorandcognitiveimpairmentinestrogendeprivedmiceexposedtochronicunpredictablemildstressimplicationforapotentialtherapyofmenopausesyndrome
AT chengang jieyupillaproprietaryherbalmedicineamelioratesmooddisorderlikebehaviorandcognitiveimpairmentinestrogendeprivedmiceexposedtochronicunpredictablemildstressimplicationforapotentialtherapyofmenopausesyndrome
AT zhangzhangjin jieyupillaproprietaryherbalmedicineamelioratesmooddisorderlikebehaviorandcognitiveimpairmentinestrogendeprivedmiceexposedtochronicunpredictablemildstressimplicationforapotentialtherapyofmenopausesyndrome